BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38066252)

  • 1. The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [
    Mamlins E; Scharbert L; Cardinale J; Krotov M; Winter E; Rathke H; Strodel B; Ankrah AO; Sathekge M; Haberkorn U; Kratochwil C; Giesel FL
    Mol Imaging Biol; 2024 Feb; 26(1):81-89. PubMed ID: 38066252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PSMA-GCK01: A Generator-Based
    Cardinale J; Giesel FL; Wensky C; Rathke HG; Haberkorn U; Kratochwil C
    J Nucl Med; 2023 Jul; 64(7):1069-1075. PubMed ID: 36759199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical translation of a PSMA inhibitor for
    Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head to head comparison performance of
    García-Pérez FO; Davanzo J; López-Buenrostro S; Santos-Cuevas C; Ferro-Flores G; Jímenez-Ríos MA; Scavuzzo A; Santana-Ríos Z; Medina-Ornelas S
    Am J Nucl Med Mol Imaging; 2018; 8(5):332-340. PubMed ID: 30510850
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Santos-Cuevas C; Davanzo J; Ferro-Flores G; García-Pérez FO; Ocampo-García B; Ignacio-Alvarez E; Gómez-Argumosa E; Pedraza-López M
    Nucl Med Biol; 2017 Sep; 52():1-6. PubMed ID: 28575794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of
    Lu K; Zhang C; Zhang Z; Kuo HT; Colpo N; Bénard F; Lin KS
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446782
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Santos-Cuevas C; Ferro-Flores G; García-Pérez FO; Jiménez-Mancilla N; Ramírez-Nava G; Ocampo-García B; Luna-Gutiérrez M; Azorín-Vega E; Davanzo J; Soldevilla-Gallardo I
    Contrast Media Mol Imaging; 2018; 2018():5247153. PubMed ID: 30534027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
    J Biomed Sci; 2018 Feb; 25(1):17. PubMed ID: 29455647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT.
    Lawal IO; Ankrah AO; Mokgoro NP; Vorster M; Maes A; Sathekge MM
    Prostate; 2017 Aug; 77(11):1205-1212. PubMed ID: 28649735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Performance of
    Vargas-Ahumada JE; González-Rueda SD; Sinisterra-Solís FA; Casanova-Triviño P; Pitalúa-Cortés Q; Soldevilla-Gallardo I; Scavuzzo A; Jimenez-Ríos MA; García-Pérez FO
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Characterization of
    Bolzati C; Gobbi C; Ferro-Flores G; Turato S; Ocampo-Garcia B; Carpanese D; Marzano C; Spolaore B; Fracasso G; Rosato A; Meléndez-Alafort L
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a New
    Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Masteri Farahani A; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
    Chem Biol Drug Des; 2020 Aug; 96(2):850-860. PubMed ID: 32279449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two peptide receptor ligands (99m)Tc-EDDA/HYNIC-Tyr(3)-octreotide and (99m)Tc-EDDA/HYNIC-(D)Glu-octagastrin for scintigraphy of medullary thyroid carcinoma.
    Kosowicz J; Mikołajczak R; Czepczyński R; Ziemnicka K; Gryczyńska M; Sowiński J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):613-28. PubMed ID: 17979564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the biodistribution of (99m)Tc-HYNIC-Lys3-Bombesin obtained with the EDDA/tricine and NA/tricine as coligands].
    Hernández-Cairo A; Perera-Pintado A; Prats-Capote A; Batista-Cuellar JF; Casacó-Santana C
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):61-5. PubMed ID: 22305264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry estimation and preliminary clinical application of [
    Yang H; Gao Z; Xu X; Liu C; Hu S; Zhang J; Song S
    Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Radiation dosimetry of
    Zhang J; Zhang J; Xu X; Lu L; Hu S; Liu C; Cheng J; Song S; Zhang Y; Shi LQ
    Sci Rep; 2020 Mar; 10(1):4179. PubMed ID: 32144340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eligibility for
    Cook GJR; Wong WL; Sanghera B; Mangar S; Challapalli A; Bahl A; Bassett P; Leaning D; Schmidkonz C
    J Nucl Med; 2023 Feb; 64(2):227-231. PubMed ID: 36302657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.